Trial
NCT00321100
Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fox Chase Cancer Center
Collaborators
—
Condition
Colorectal Neoplasms
Intervention
bevacizumab
Why stopped
Enrollment closed 10/15/2008 based on data about KRAS.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-01-12